Dr. Jonathan Natividad Jarvina, MD

Dr. Jarvina practices at Verde Valley Medical Center in Cottonwood, Arizona, part of Northern Arizona Healthcare.

Dr. Jarvina's NPI, 1609105204, was assigned on December 10, 2009. Dr. Jarvina holds Arizona license 46391.

Dr. Jarvina's primary practice is Verde Valley Medical Center, at 269 South Candy Lane, Cottonwood, AZ 86326 in Yavapai County. The practice phone is (928) 773-2357.

Dr. Jarvina's primary practice is Verde Valley Medical Center in Cottonwood, Arizona, part of Northern Arizona Healthcare. The medical group on file is Northern Arizona Healthcare. Dmand AI also links Dr. Jarvina to 2 more medical groups, 1 breast imaging center and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jarvina practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Jarvina's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Jarvina is licensed in Arizona.

CMS data shows 709 Medicare services from Dr. Jarvina across 4 procedure codes in 2024, for 134 Medicare patients. Medicare paid $55,085 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 134 Medicare patients who saw Dr. Jarvina in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jarvina's median patient age at 73, with 50% women.

In 2024, Dr. Jarvina wrote 448 Medicare Part D claims for 112 patients. 77% of them were for generic drugs. CMS names the drug for 117 of them, across 7 drugs with 11 or more claims each, at $22,093 in total drug cost. In 2023, CMS named 1,176 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Jarvina for performance year 2024, reported as part of a group. Dr. Jarvina accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 199 general payments to Dr. Jarvina from 35 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. Novo Nordisk Inc paid the most, $657.